Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Consolidated Net Income (2020 - 2025)

Pulse Biosciences has reported Consolidated Net Income over the past 6 years, most recently at -$19.4 million for Q3 2025.

  • Quarterly results put Consolidated Net Income at -$19.4 million for Q3 2025, down 52.73% from a year ago — trailing twelve months through Dec 2025 was -$55.3 million (down 203.23% YoY), and the annual figure for FY2025 was $72.8 million, up 35.82%.
  • Consolidated Net Income for Q3 2025 was -$19.4 million at Pulse Biosciences, down from -$19.2 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for PLSE hit a ceiling of $87.8 million in Q4 2024 and a floor of -$19.4 million in Q3 2025.
  • Median Consolidated Net Income over the past 5 years was -$14.0 million (2022), compared with a mean of -$6.6 million.
  • Biggest five-year swings in Consolidated Net Income: soared 429.21% in 2023 and later tumbled 68.39% in 2025.
  • Pulse Biosciences' Consolidated Net Income stood at -$15.4 million in 2021, then soared by 40.34% to -$9.2 million in 2022, then soared by 429.21% to $30.3 million in 2023, then skyrocketed by 189.99% to $87.8 million in 2024, then crashed by 122.06% to -$19.4 million in 2025.
  • The last three reported values for Consolidated Net Income were -$19.4 million (Q3 2025), -$19.2 million (Q2 2025), and -$16.8 million (Q1 2025) per Business Quant data.